Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Neurobiol Aging. 2012 Jun 5;33(9):2231.e15–2231.e30. doi: 10.1016/j.neurobiolaging.2012.04.020

Table 2.

Characteristics of the GWAS datasets

Cases Controls
Cases

(N)
Female

(N, %)
Age at
onset
(mean ±
SD)
Age at
exam
(mean ±
SD)
APOE ε4

(allele %)
Controls

(N)
Female

(N, %)
Age at
exam
(mean ±
SD)
APOE ε4

(allele %)
ACT 566 357(63%) 83.90 (4.8) 84.72 (4.9) 0.26 1696 947 (56%) 81.08 (6.0) 0.11
ADC1 1566 850 (54%) 72.47 (7.1) 81.61 (7.0) 0.42 515 305 (59%) 75.00 (8.0) 0.16
ADC2 738 377 (51%) 73.19 (7.1) 80.06 (7.2) 0.39 160 110 (69%) 75.68 (7.9) 0.16
ADNI 268 113 (42%) 75.30 (7.2) 77.96 (6.5) 0.42 173 70 (40%) 78.6 (5.5) 0.14
GenADA 669 380 (57%) 74.59 (6.2) 80.36 (6.2) 0.38 713 456 (64%) 74.21 (7.0) 0.13
UM/VU/MSSM 1186 764 (64%) 74.06 (7.8) 77.48 (6.9) 0.36 1135 696 (61%) 74.00 (8.3) 0.12
MIRAGE 509 324 (64%) 71.16 (6.5) 75.97 (6.6) 0.36 753 440 (58%) 72.04 (7.2) 0.23
NIA-LOAD 1811 1176 (65%) 73.57 (6.7) 82.49 (7.1) 0.46 1575 947 (60%) 73.99 (8.5) 0.20
OHSU 132 81 (61%) 86.10 (5.5) 90.40 (5.2) 0.23 153 84 (55%) 83.86 (7.6) 0.08
TGEN2 864 633 (73%) 74.91 (7.2) 82.00 (7.6) 0.40 493 186 (38%) 80.19 (8.7) 0.11
TOTAL 8309 5055 (61%) -- -- -- 7366 4241 (58%) -- --